Reader TTS

If you have a high-deductible health insurance plan, you know that one of the drawbacks is, well, a high deductible. And that might make you balk at getting tested for coronavirus. The

Internal Revenue Service is taking some of your hesitation away. Under new IRS guidance, your employer's high-deductible health plan (HDHP) can waive the out-of-pocket costs of COVID-19

testing and treatment without running afoul of tax law or making you pay through your health savings account (HSA). Previous rules forbid high-deductible plans paying for testing and

treatment of coronavirus before a patient had met their entire deductible. Those costs can be considerable. In 2020, high-deductible plans must have a deductible of at least $1,400 for an

individual or $2,800 for a family. An HDHP's total yearly out-of-pocket expenses (including deductibles, copayments and coinsurance) can't be more than $6,900 for an individual or

$13,800 for a family. THROUGHOUT THE TAX SEASON, CHECK FOR THE LATEST UPDATES AND RESOURCES   Jodi Jacobson/Getty Images MORE ON CORONAVIRUS Individuals with qualifying high-deductible plans

are eligible for HSAs, to which they can contribute pretax up to $3,550 for individuals and $7,100 for families. Contributions reduce your taxable income. Those 55 and older can contribute

an additional $1,000. They can withdraw that money tax free, if used for qualified medical expenses, and roll over any remaining balance to the next year. After age 65, you may no longer

make contributions to a health savings account if you enroll in Medicare, but you can make withdrawals. Bear in mind, however, that employers are not being required by the IRS to waive

coronavirus costs. Rather, they have the option to exempt the costs from deductible requirements without jeopardizing their tax treatment. Some employers, especially those that are

self-insured, may choose not to follow suit. The IRS ruling also protects the tax status of HSAs in the event an HDHP covers coronavirus costs before the deductible is met. "It [the

ruling] should encourage more people to get tested, but whether the test is available or not is another question,” said Alison Moore, vice president of HealthSavings, an HSA provider. “The

federal government is doing everything they can to be proactive for the treatment of this virus."